BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26180054)

  • 1. Hepatitis B virus hijacks CTHRC1 to evade host immunity and maintain replication.
    Bai L; Zhang W; Tan L; Yang H; Ge M; Zhu C; Zhang R; Cao Y; Chen J; Luo Z; Ho W; Liu F; Wu K; Wu J
    J Mol Cell Biol; 2015 Dec; 7(6):543-56. PubMed ID: 26180054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
    Chen J; Xu W; Chen Y; Xie X; Zhang Y; Ma C; Yang Q; Han Y; Zhu C; Xiong Y; Wu K; Liu F; Liu Y; Wu J
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
    Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J
    Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus polymerase impairs interferon-α-induced STA T activation through inhibition of importin-α5 and protein kinase C-δ.
    Chen J; Wu M; Zhang X; Zhang W; Zhang Z; Chen L; He J; Zheng Y; Chen C; Wang F; Hu Y; Zhou X; Wang C; Xu Y; Lu M; Yuan Z
    Hepatology; 2013 Feb; 57(2):470-82. PubMed ID: 22996189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication.
    Tan G; Xiao Q; Song H; Ma F; Xu F; Peng D; Li N; Wang X; Niu J; Gao P; Qin FX; Cheng G
    Cell Mol Immunol; 2018 Mar; 15(3):272-281. PubMed ID: 28194021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
    Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
    Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 To Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism.
    Yang Q; Zhang Q; Zhang X; You L; Wang W; Liu W; Han Y; Ma C; Xu W; Chen J; Yang H; Wan P; Zhou Y; Liu Y; Wu K; Yang Z; Wu J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
    Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
    Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action.
    Yu Y; Wan P; Cao Y; Zhang W; Chen J; Tan L; Wang Y; Sun Z; Zhang Q; Wan Y; Zhu Y; Liu F; Wu K; Liu Y; Wu J
    Sci Rep; 2017 May; 7(1):1729. PubMed ID: 28496097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-27, a cytokine, and IFN-λ1, a type III IFN, are coordinated to regulate virus replication through type I IFN.
    Cao Y; Zhang R; Zhang W; Zhu C; Yu Y; Song Y; Wang Q; Bai L; Liu Y; Wu K; Wu J
    J Immunol; 2014 Jan; 192(2):691-703. PubMed ID: 24337382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hepatitis B virus surface and e antigens inhibit major vault protein signaling in interferon induction pathways.
    Liu S; Peng N; Xie J; Hao Q; Zhang M; Zhang Y; Xia Z; Xu G; Zhao F; Wang Q; Han T; Zhu Y
    J Hepatol; 2015 May; 62(5):1015-23. PubMed ID: 25481566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2
    Xu S; Huang J; Xun Z; Li S; Fu Y; Lin N; Wu W; Chen T; Liu C; Ou Q
    Microbiol Spectr; 2022 Dec; 10(6):e0155722. PubMed ID: 36314949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
    Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
    J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice.
    Ebert G; Poeck H; Lucifora J; Baschuk N; Esser K; Esposito I; Hartmann G; Protzer U
    Gastroenterology; 2011 Aug; 141(2):696-706, 706.e1-3. PubMed ID: 21684282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes.
    Hou ZH; Han QJ; Zhang C; Tian ZG; Zhang J
    Liver Int; 2014 Jan; 34(1):58-68. PubMed ID: 23890093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the complexity of hepatitis B virus: from molecular understanding to therapeutic strategy in 50 years.
    Liu B; Wen X; Huang C; Wei Y
    Int J Biochem Cell Biol; 2013 Sep; 45(9):1987-96. PubMed ID: 23819994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-enolase regulates hepatitis B virus replication through suppression of the interferon signalling pathway.
    Xiang-Chun D; Xiao-Qing Y; Ting-Ting Y; Zhen-Hui L; Xiao-Yan L; Xia L; Yan-Chao H; Yi-Xuan Y; Li-Na M
    J Viral Hepat; 2018 Mar; 25(3):289-295. PubMed ID: 29080231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus-induced calreticulin protein is involved in IFN resistance.
    Yue X; Wang H; Zhao F; Liu S; Wu J; Ren W; Zhu Y
    J Immunol; 2012 Jul; 189(1):279-86. PubMed ID: 22661095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Virus Stimulated Fibronectin Facilitates Viral Maintenance and Replication through Two Distinct Mechanisms.
    Ren S; Wang J; Chen TL; Li HY; Wan YS; Peng NF; Gui XE; Zhu Y
    PLoS One; 2016; 11(3):e0152721. PubMed ID: 27023403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of
    Tan G; Xu F; Song H; Yuan Y; Xiao Q; Ma F; Qin FX; Cheng G
    Front Immunol; 2018; 9():1872. PubMed ID: 30150992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.